The nucleotide sequences of two monoclonal antibody-resistant mutant viruses predict changes from the wild-type in the number of potential glycosylation sites (Asn-X-Thr/Ser) in the mutant haemagglutinin-neuraminidase (HN) glycoproteins of the Beaudette C strain of Newcastle disease virus. The HN glycoproteins of these mutants, F5 and Z18, migrate either slower (F5) or faster (Z18) than that of the wild-type in SDS-PAGE. HN proteins synthesized in chick embryo fibroblasts following infection by either mutant or wild-type virus in the presence of tunicamycin (an inhibitor of glycosylation), comigrate on SDS-PAGE. These results confirm that the HN protein of the mutant virus, F5, has gained a glycosylation site at Asn(323)-Ser-Ser and that the conserved potential glycosylation site at Asn(481)-His-Thr is indeed glycosylated in the HN protein of the wild-type Beaudette C strain of Newcastle disease virus but is lost in that of the mutant virus, Z18.
Three antigenic sites on the haemagglutinin-neuraminidase (HN) glycoprotein of the Newcastle disease virus (NDV) strain Beaudette C have recently been identified on the basis of competitive binding assay experiments using anti-HN monoclonal antibodies (MAbs). Direct RNA sequencing of the HN genes of mutant viruses resistant to various neutralizing anti-HN MAbs and comparison of the nucleotide sequences with that of the corresponding wild-type virus has led to the mapping of seven neutralizing epitopes within the HN protein of NDV (Yusoff et al., 1988) . A schematic representation of the location of these epitopes on the hydropathy profile of the HN protein is presented in Fig. 1 .
Here we report the effect of amino acid substitutions on potential glycosylation sites at two of the epitopes, B3 and C1. MAbs NHN-6 and NHN-1 recognize the epitopes B3 and C1, respectively. Both antibodies exhibit haemagglutination inhibition (HI) and neutralization (NT) functions but do not inhibit neuraminidase activity when N-acetylneuramin lactose is used as substrate. MAb NHN-6, however, has very low HI and NT titres, which are approximately 32-fold lower than MAb NHN-1 (Yusoff et al., 1988) .
Two NDV mutants which are resistant to MAb NHN-6, F5 and F6, each have a mutation changing amino acid Pro(325) to either Ser (F5) or Leu (F6) at the B3 epitope. Thus, the mutation in F5 appears to create an additional potential glycosylation site ] at that position on the HN protein primary sequence whereas there would be no predicted change in the number of potential glycosylation sites in the F6 mutant. The HN protein of F5 was observed to migrate more slowly than that of the wild-type virus on SDS-PAGE. Another mutant, Z18 (resistant to MAb NHN-1 which recognizes the C1 epitope), has a mutation that changes amino acid Asn(481) to Asp resulting in the loss of the potential glycosylation site, Asn- (Millar et al., 1986) showing the epitopes A1 to A3, B1 to B3 and C1.
His-Thr, at that position on the HN protein. The C1 epitope is similar to the site IV epitope located on strain D26 by Gotoh et al. (1988) who further showed that a mutation at that site resulted in a faster migrating HN protein due to the loss of a glycosylation site. However, initially we did not see any difference between the migration rate of our Z18 mutant HN protein and that of the wild-type virus (Yusoff et al., 1988) .
To determine whether these mutations do indeed affect glycosylation of the HN protein, the wild-type virus and the F5, F6 and Z18 mutants were grown in chick embryo fibroblasts (CEF) in the presence or absence of tunicamycin (20 Ixg/ml). The HN proteins were subjected to SDS-PAGE (Laemmli, 1970) in the presence of 2-mercaptoethanol for an extended period of time (5 h at 40 mA in 10~ polyacrylamide, using 12.5 cm long gels) and then Western-blotted. The HN protein was detected using MAb 14 which had previously been shown to recognize a linear epitope on the HN glycoprotein common to all of these mutants (Chambers et al., 1988) . As shown in Fig. 2 , all of the wild-type and mutant non-glycosylated HN proteins comigrated when synthesis had occurred in the presence of tunicamycin (Mr 63K, lanes 3 to 6). However, when HN proteins were synthesized in the absence of tunicamycin, only the HN protein of the F6 mutant comigrated with that of the wild-type virus (Mr 74K, lanes 11 and 9) as anticipated. The HN protein of the F5 mutant migrated more slowly than the others (Mr 77K, lane 10), confirming that the F5 mutant had gained an extra glycosylation site on the HN protein. In addition, in this extended SDS-PAGE run, the HN protein of the MAb NHN-l-resistant mutant, Z18, migrated slightly faster than that of the wild-type virus (Mr 71K, lane 8), indicating a loss of a glycosylation site at epitope C1 (otherwise known as site IV; Gotoh et al., 1988) . That the site of extra glycosylation in the F5 mutant is between amino acid residues 130 and 385 in the HN glycoprotein has been confirmed by chemical cleavage of the Asp-Probonds of the HN protein, followed by Western blotting against MAb 14 (Piszkiewicz et al., 1970; Samson et al., 1988) which shows that all partial digests of the HN protein from mutant F5 which contain the 130 to 385 fragment are shifted up in size compared with that of the wild-type (R. Prince, unpublished data).
Gotoh et al. (1988) proposed that the amino acids Tyr(479) and Arg(480) which precede Asn(481) are required for the binding of MAb 41 and MAb 42 to their antigenic site IV in strain D26. These two amino acids are found at the same positions in strains Beaudette C, Ulster 2C (Millar et al., 1986 (Millar et al., , 1988 ) and D26 but not in Miyadera (Gotoh et al., 1988) or Italien (Wemers et al., 1987) . MAb NHN-1, however, binds to both the Italien and Ulster strains, on the basis of indirect immunoperoxidase assays, although no HI was observed (D. Alexander, personal Virions were adsorbed to confluent monolayers for 30 min at 37 °C, washed and incubated in the presence or absence of tunicamycin (20 ~tg/ml, Sigma) in fresh growth medium for 9 h. Monolayers were then rinsed, resuspended in 300 ~tl of reduced SDS sample buffer (Laemmli, 1970) and boiled for 2 min before electrophoresis on a 12.5 cm long, 10~ polyacrylamide gel (Laemmli, 1970) . Proteins from the gel were then blotted onto nitrocellulose (Samson, 1986) . Mr markers were also electroblotted from the same gel: phosphorylase b (Mr 92K), bovine serum albumin (Mr 68K) and alcohol dehydrogenase (M r 41K), and stained with India ink (Hancock & Tsang, 1983) . The remaining nitrocellulose was stained with peroxidaseconjugated rabbit anti-mouse serum after incubation with MAb 14 as described by Samson (1986) . communication). This implies that these amino acid residues may not be involved in the binding of MAb NHN-1 to site C1 in Beaudette C.
In conclusion, studies with the Z18 mutant of Beaudette C strain of NDV show that the sequence Asn-His-Thr (481 to 483), which is one of the five conserved potential glycosylation sites within the HN protein, is in fact glycosylated in ovo and in CEF. This corresponds with the similar finding that this site is glycosylated in the D26 strain of NDV (Gotoh et al., 1988) . 
